文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

重症COVID-19患者微血管功能障碍:一项先导研究

Microvascular Dysfunction in Patients with Critical Covid-19, a Pilot Study.
PubMed 文献 · Shock · 2021-01-01
一句话结论小型先导研究显示,重症COVID-19患者住院期间内皮依赖性和非依赖性皮肤微血管舒张均受损,发病3个月后内皮依赖性舒张可能仍未完全恢复。

该先导研究纳入12例接受无创或有创机械通气的重症COVID-19患者,在住院期间两个时间点及发病至少3个月后,用激光散斑对比成像结合离子导入乙酰胆碱(ACh)和硝普钠(SNP)评估皮肤微血管反应性,并与12名对照比较。结果显示,研究第1天患者基础皮肤灌注高于对照,ACh介导的内皮依赖性舒张(P=0.002)和SNP介导的内皮非依赖性舒张(P=0.01)均减弱,ACh/SNP比值降低(0.50±0.36 vs 对照0.91±0.49,P=0.02)。发病3个月后存活患者ACh介导的血管舒张较对照有降低趋势(P=0.08)。作者认为重症COVID-19与微血管损伤相关,尤其内皮功能明显受损,且3个月时微血管功能可能未完全恢复。

要点

  • 重症COVID-19患者研究第1天ACh介导的内皮依赖性皮肤微血管舒张较对照减弱(P=0.002)。
  • 重症COVID-19患者研究第1天SNP介导的内皮非依赖性皮肤微血管舒张较对照减弱(P=0.01)。
  • 患者ACh/SNP比值0.50±0.36,低于对照的0.91±0.49(P=0.02)。
  • 发病3个月后存活患者ACh介导的血管舒张较对照有降低趋势(P=0.08)。

适用人群与场景

  • 12例接受无创或有创机械通气的重症COVID-19患者。
  • 12名2020年期间无确诊或疑似COVID-19感染的对照。

研究设计与关键结果

  • 研究类型:先导研究;样本量:12例重症COVID-19患者和12名对照。
  • 干预与对照:在住院期间两个独立日(研究第1天和第2天)及发病至少3个月后(研究第3天),用激光散斑对比成像在离子导入乙酰胆碱(ACh)和硝普钠(SNP)前后评估皮肤灌注,分别确定内皮依赖性和内皮非依赖性血管舒张;对照同样接受检查。
  • 主要终点结果:与对照相比,重症COVID-19患者研究第1天基础皮肤灌注更高,ACh介导的内皮依赖性血管舒张减弱(P=0.002),SNP介导的内皮非依赖性血管舒张减弱(P=0.01)。
  • ACh/SNP比值在患者中显著降低:患者0.50±0.36 vs 对照0.91±0.49(P=0.02)。
  • 发病3个月后,存活患者ACh介导的血管舒张较对照有降低趋势(P=0.08)。

证据类型、等级与局限

  • 证据类型:先导研究。
  • 局限:作者自述为小样本先导研究(small-sized pilot study)。

对床旁实践的改变

  • 作者认为,重症COVID-19感染与微血管损伤相关,尤其表现为内皮功能明显受损。
  • 作者认为,微血管功能在发病3个月后可能未完全恢复。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Endothelial and microvascular dysfunction may be a key pathogenic feature of severe COVID-19. The aim of this study was to investigate endothelial-dependent and endothelial-independent skin microvascular reactivity in patients with critical COVID-19.

METHODS: Twelve patients with COVID-19 treated with non-invasive or invasive mechanical ventilation were included in the study. We investigated skin microvascular reactivity on 2 separate days during hospitalization (study day 1 and 2) and at least 3 months after disease onset (study day 3). Twelve controls with no confirmed or suspected COVID-19 infection during 2020 were also examined. Skin perfusion was investigated through Laser Speckle Contrast Imaging before and after iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP) to determine the endothelial-dependent and the endothelial-independent vasodilation, respectively.

RESULTS: Compared to controls, patients with critical COVID-19 had higher basal skin perfusion and reduced responses to endothelial-dependent (ACh, P = 0.002) and endothelial-independent (SNP, P = 0.01) vasodilator drugs on study day 1. In addition, the ACh/SNP ratio was significantly reduced in patients (0.50 ± 0.36 vs. 0.91 ± 0.49 in controls, P = 0.02). Three months after disease onset, surviving patients tended to have reduced ACh-mediated vasodilation compared to controls (P = 0.08).

CONCLUSIONS: This small-sized pilot study demonstrates that critical COVID-19 infection is associated with microvascular impairment and, in particular, a markedly reduced endothelial function. Our results also suggest that microvascular function may not be fully recovered 3 months after disease onset.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Tehrani S, Gille-Johnson P. Microvascular Dysfunction in Patients with Critical Covid-19, a Pilot Study. Shock. 2021. PMID: 33958544. doi:10.1097/SHK.0000000000001803

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。